These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 8191242)
1. Five versus ten days treatment of streptococcal pharyngotonsillitis: a randomized controlled trial comparing cefpodoxime proxetil and phenoxymethyl penicillin. Portier H; Chavanet P; Waldner-Combernoux A; Kisterman JP; Grey PC; Ichou F; Safran C Scand J Infect Dis; 1994; 26(1):59-66. PubMed ID: 8191242 [TBL] [Abstract][Full Text] [Related]
2. Cefpodoxime proxetil vs. penicillin V in pediatric streptococcal pharyngitis/tonsillitis. Dajani AS; Kessler SL; Mendelson R; Uden DL; Todd WM Pediatr Infect Dis J; 1993 Apr; 12(4):275-9. PubMed ID: 8483620 [TBL] [Abstract][Full Text] [Related]
3. Effective short-course treatment of acute group A beta-hemolytic streptococcal tonsillopharyngitis. Ten days of penicillin V vs 5 days or 10 days of cefpodoxime therapy in children. Pichichero ME; Gooch WM; Rodriguez W; Blumer JL; Aronoff SC; Jacobs RF; Musser JM Arch Pediatr Adolesc Med; 1994 Oct; 148(10):1053-60. PubMed ID: 7921095 [TBL] [Abstract][Full Text] [Related]
4. Comparison of oral cefpodoxime proxetil and penicillin V potassium in the treatment of group A streptococcal pharyngitis/tonsillitis. The Cefpodoxime Pharyngitis Study Group. Brown RJ; Batts DH; Hughes GS; Greenwald CA Clin Ther; 1991; 13(5):579-88. PubMed ID: 1799915 [TBL] [Abstract][Full Text] [Related]
5. Five day treatment of pharyngotonsillitis with cefpodoxime proxetil. Portier H; Chavanet P; Gouyon JB; Guetat F J Antimicrob Chemother; 1990 Dec; 26 Suppl E():79-85. PubMed ID: 2127268 [TBL] [Abstract][Full Text] [Related]
6. Cefetamet pivoxil in the treatment of pharyngotonsillitis due to group A beta-hemolytic streptococci: preliminary report. Gervaix A; Brighi L; Halpérin DS; Suter S J Chemother; 1995 May; 7 Suppl 1():21-4. PubMed ID: 8618109 [TBL] [Abstract][Full Text] [Related]
7. Cost saving of 5-day therapy with cefpodoxime proxetil versus standard 10-day beta-lactam therapy for recurrent pharyngotonsillitis in adults. A prospective general practice study. Pelc A; Portier H; Gehanno P; Fiessinger S; Ichou F Pharmacoeconomics; 1996 Sep; 10(3):239-50. PubMed ID: 10172792 [TBL] [Abstract][Full Text] [Related]
8. Pharyngitis/tonsillitis: European and United States experience with cefpodoxime proxetil. Dajani AS Pediatr Infect Dis J; 1995 Apr; 14(4 Suppl):S7-11. PubMed ID: 7792129 [TBL] [Abstract][Full Text] [Related]
9. Cefpodoxime proxetil: a review of its use in the management of bacterial infections in paediatric patients. Fulton B; Perry CM Paediatr Drugs; 2001; 3(2):137-58. PubMed ID: 11269640 [TBL] [Abstract][Full Text] [Related]
10. Cefpodoxime proxetil. An appraisal of its use in antibacterial cost-containment programmes, as stepdown and abbreviated therapy in respiratory tract infections. Balfour JA; Benfield P Pharmacoeconomics; 1996 Aug; 10(2):164-78. PubMed ID: 10163419 [TBL] [Abstract][Full Text] [Related]
11. Comparative study of cefetamet pivoxil and penicillin V in the treatment of group A beta-hemolytic streptococcal pharyngitis. Ramet J; Pierard D; Vandenberghe P; De Boeck K Chemotherapy; 1992; 38 Suppl 2():33-7. PubMed ID: 1516463 [TBL] [Abstract][Full Text] [Related]
12. Therapy for pharyngitis and tonsillitis caused by group A beta-hemolytic streptococci: a meta-analysis comparing the efficacy and safety of cefadroxil monohydrate versus oral penicillin V. Deeter RG; Kalman DL; Rogan MP; Chow SC Clin Ther; 1992; 14(5):740-54. PubMed ID: 1468091 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of short-course therapy with the ketolide telithromycin compared with 10 days of penicillin V for the treatment of pharyngitis/tonsillitis. Norrby SR; Rabie WJ; Bacart P; Mueller O; Leroy B; Rangaraju M; Butticaz-Iroudayassamy E Scand J Infect Dis; 2001; 33(12):883-90. PubMed ID: 11868759 [TBL] [Abstract][Full Text] [Related]
14. Penicillin V four times daily for five days versus three times daily for 10 days in patients with pharyngotonsillitis caused by group A streptococci: randomised controlled, open label, non-inferiority study. Skoog Ståhlgren G; Tyrstrup M; Edlund C; Giske CG; Mölstad S; Norman C; Rystedt K; Sundvall PD; Hedin K BMJ; 2019 Oct; 367():l5337. PubMed ID: 31585944 [TBL] [Abstract][Full Text] [Related]
15. Cefetamet pivoxil in the treatment of pharyngitis/tonsillitis in children and adults. Guggenbichler JP Drugs; 1994; 47 Suppl 3():27-33; discussion 34. PubMed ID: 7518764 [TBL] [Abstract][Full Text] [Related]
16. Five days of erythromycin estolate versus ten days of penicillin V in the treatment of group A streptococcal tonsillopharyngitis in children. Pharyngitis Study Group. Adam D; Scholz H Eur J Clin Microbiol Infect Dis; 1996 Sep; 15(9):712-7. PubMed ID: 8922570 [TBL] [Abstract][Full Text] [Related]
17. Azithromycin versus penicillin V in the treatment of paediatric patients with acute streptococcal pharyngitis/tonsillitis. Paediatric Azithromycin Study Group. O'Doherty B Eur J Clin Microbiol Infect Dis; 1996 Sep; 15(9):718-24. PubMed ID: 8922571 [TBL] [Abstract][Full Text] [Related]
18. Loracarbef versus penicillin V in the treatment of streptococcal pharyngitis and tonsillitis. Müller O; Spirer Z; Wettich K Infection; 1992; 20(5):301-8. PubMed ID: 1428189 [TBL] [Abstract][Full Text] [Related]
19. Clindamycin in persisting streptococcal pharyngotonsillitis after penicillin treatment. Orrling A; Stjernquist-Desatnik A; Schalén C; Kamme C Scand J Infect Dis; 1994; 26(5):535-41. PubMed ID: 7855551 [TBL] [Abstract][Full Text] [Related]
20. Loracarbef versus penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis in adults. McCarty J; Hernon Y; Linn L; Therasse DG; Molina A; Bleile N Clin Ther; 1992; 14(1):30-40. PubMed ID: 1576624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]